Compare
Weed, Inc. vs NRC Health vs Incyte Corp vs Icon PLC
| Latest fiscal year | Weed, Inc. BUDZ | NRC Health NRC | Incyte Corp INCY | Icon PLC ICLR |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $0 | $137.39M | $5.14B | $8.25B |
| Revenue growth (YoY) | n/a | -4.0% | +21.2% | +0.8% |
| Gross margin | n/a | n/a | 92.8% (computed) | n/a |
| Operating margin | n/a | 16.4% | 29.5% | 5.4% |
| Net margin | n/a | 8.4% | 25.0% | 2.8% |
| Net income | -$1.37M | $11.60M | $1.29B | $229.34M |
| EPS (Diluted) | -$0.01 | $50.00 | $6.41 | $2.90 |
| Operating cash flow | -$195.1K | $26.45M | $1.41B | $1.04B |
| Free cash flow | n/a | $15.74M | n/a | $861.99M |
| Cash & equivalents | n/a | $4.14M | $3.10B | $647.29M |
| Total assets | $559.9K | $134.88M | $6.96B | $16.27B |
| Total liabilities | $1.25M | $120.89M | $1.79B | $7.08B |
| Shareholders' equity | -$688.4K | $13.99M | $5.17B | $9.19B |
| Return on year-end equity | n/a | 82.9% | 24.9% | 2.5% |
| Shares outstanding | 147.43M | 22.64M | 198.46M | 76.57M |
Revenue, most recent five fiscal years
| Fiscal year | Weed, Inc. | NRC Health | Incyte Corp | Icon PLC |
|---|---|---|---|---|
| Latest | $0 Ended 2025-12-31 | $137.39M Ended 2025-12-31 | $5.14B Ended 2025-12-31 | $8.25B Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2024-12-31 | $143.06M Ended 2024-12-31 | $4.24B Ended 2024-12-31 | $8.19B Ended 2024-12-31 |
| 2 years earlier | $0 Ended 2023-12-31 | $148.58M Ended 2023-12-31 | $3.70B Ended 2023-12-31 | $8.05B Ended 2023-12-31 |
| 3 years earlier | $0 Ended 2022-12-31 | $151.57M Ended 2022-12-31 | $3.39B Ended 2022-12-31 | $7.74B Ended 2022-12-31 |
| 4 years earlier | n/a | $147.95M Ended 2021-12-31 | $2.99B Ended 2021-12-31 | $5.48B Ended 2021-12-31 |